Medincell Depreciation & Amortization Growth & History (MEDCL)

Medincell's depreciation and amortization was €1.8M for fiscal 2026.

View full Medincell company overview

Medincell annual depreciation and amortization history

Medincell annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20262026-03-31€1.8M−€166,000−8.34%
20252025-03-31€2.0M€271,000+15.76%
20242024-03-31€1.7M€54,000+3.24%
20232023-03-31€1.7M€149,000+9.83%
20222022-03-31€1.5M€177,000+13.22%
20212021-03-31€1.3M

Medincell depreciation and amortization trends

Over the last five fiscal years, Medincell's depreciation and amortization increased from €1.3M to €1.8M, a change of €485,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Medincell source filings ↗

Community posts

It’s quiet here.

No posts about MEDCL yet. Start the conversation.

Write the first post